Should You Hold Illumina (ILMN)?
Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” first quarter 2025 investor letter. A copy of the letter can be downloaded here.
Illumina Inc. (ILMN)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Bourgeon Capital John Zaro | 80,428 | $6,381,158 | 1.37% | |
| 2. | Impax Asset Management Ian Simm | 50,270 | $3,988,422 | -13% | 0.02% |
| 3. | Solstein Capital Nadine Terman And Jc Torres | 71 | $5,633 | 0% | |
| 4. | Beech Hill Partners Paul Cantor, Joseph Weiss, And Will Wurm | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $137.18 | 692 | Officer, Director | 14,861 | 2024-02-22 | Filing | |
| $135.69 | 1,553 | Officer, Director | 14,169 | 2024-02-22 | Filing | |
| $134.91 | 5,085 | Officer, Director | 12,616 | 2024-02-22 | Filing | |
| $43.87 | 315 | Director | 670 | 2012-04-18 | Filing | |
| $36.54 | 809 | Director | 809 | 2012-01-17 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $112.84 | 315 | Officer | 8,314 | 2023-11-07 | Filing | |
| $167.04 | 500 | Officer | 45,524 | 2023-08-22 | Filing | |
| $190.08 | 500 | Officer | 46,022 | 2023-07-24 | Filing | |
| $200.00 | 500 | Officer | 46,522 | 2023-06-22 | Filing | |
| $209.67 | 1,676 | Officer | 47,022 | 2023-05-22 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 4,179,011 | $334,320,880 | 0.86% | |
| 2. | 1,050,203 | $83,323,106 | 0.06% | |
| 3. | 922,281 | $73,173,775 | 0.12% | |
| 4. | 669,730 | $53,136,379 | 0.22% | |
| 5. | 525,664 | $41,706,182 | 0.13% |
News See All
15 Recent Activist Investor Campaigns
Economic uncertainty and market volatility are some of the factors fueling activist investor campaigns in 2025.
12 Best Diagnostics Stocks to Invest In Right Now
According to a report by Mordor Intelligence, the clinical diagnostics market has a size of $88.79 billion as of 2025.
15 Best Biotech Stocks to Buy According to Billionaires
Although biotech stocks had a "challenging" year in 2024, JPMorgan believes that some of the industry's companies could see significant growth in the months to come.
Jim Cramer’s Latest Lightning Round: 7 Stocks in Focus
On Thursday, Jim Cramer, the host of Mad Money, pointed out that the ongoing fears surrounding President Donald Trump's aggressive tariff policies continued to impact the market.
Why These 15 Large-Cap Stocks Are Plunging So Far In 2025
The big and large-cap stocks have spearheaded the rally in the past two years, but Wall Street’s expectations have gotten ahead of many of their fundamentals.
What Makes Illumina (ILMN) an Attractive Opportunity?
Brown Advisors, an investment management company, released its “Brown Advisors Global Leaders Strategy” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here.
What Makes Illumina (ILMN) a Long Term Bet?
Baron Funds, an investment management company, released its “Baron Fifth Avenue Growth Fund” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here.
Top 10 AI Stocks Buzzing on Latest News
Investors are continuing to assess the impact of new LLMs in the AI industry. X.
Jim Cramer Discusses These 10 Stocks & Dissects President Trump's China Tariffs
In a recent appearance on CNBC's Squawk on the Street, Jim Cramer discussed China's retaliatory actions against President Trump's tariffs.
Billionaire Hedge Funds
